Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J VAN BREEMEN

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Inherited Metabolic Disease|March 30, 2011
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodiesJohannes M F G Aerts, Wouter W Kallemeijn, Wouter Wegdam, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Inherited Metabolic Disease|March 30, 2011
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodiesJohannes M F G Aerts, Wouter W Kallemeijn, Wouter Wegdam, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Pageof 3